Amanta Healthcare

Amanta Healthcare Limited - IPO

MAINBOARD

Amanta Healthcare IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
₹10 per share
Lot Size
0
GMP
₹0
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Share holding pre issue
28829351
Share holding post issue
41329351
Total Issue Size
-
Fresh Issue
1,25,00,000 shares (aggregating up to ₹0.00 Cr)
Offer for Sale
-
DRHP Status
SEBI Approval Received

Amanta Healthcare IPO Lot Size

ApplicationLotsSharesAmount
To be announced

Amanta Healthcare IPO Reservation

Promoter Holding

Pre Issue:58.59%
Post Issue:-
Promoter Names:
Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, Milcent Appliances Private Limited.

Documents

  ›  Amanta Healthcare IPO DRHP

Amanta Healthcare IPO Valuations

ROE:5.27%
ROCE:12.76%
DEBT/EQUITY:3.10
RONW:5.48%
PAT MARGIN:1.30%

Amanta Healthcare Limited Financial Information

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets379.7352.12374.06379.28
Revenue203.87281.61262.7226.27
Profit After Tax4.293.41-2.0953.91
Net Worth90.5866.2962.8864.97
Reserves and Surplus61.7539.4636.0538.14
Total Borrowing196.59205.23215.66221.7
Amount in ₹ Crore

About Amanta Healthcare IPO

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.

The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.

The company markets products through three business units:
  1. national sales,
  2. international sales and
  3. product partnering with various foreign and Indian pharmaceutical companies.

The company manufactures over 45 generic products, marketing them under our brands in India through 189 distributors and stockists.

The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2024, the company exported branded products to 19 countries.

As of December 31, 2024, the company has a team of 128 employees at its formulation and development and quality laboratory.
Competitive Strengths

  • Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
  • Large manufacturing capabilities
  • Wide Domestic and International Marketing Network.

  • Experienced management team supported by a large, diverse and skilled workforce.

Strength Of Amanta Healthcare IPO

To be announced

Risk Of Amanta Healthcare IPO

To be announced

Objectives Amanta Healthcare IPO

  1. Funding capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat;
  2. Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat; and
  3. General corporate purposes.

Company Contact Details

Amanta Healthcare Limited
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/

Registrar Contact Details

Name: MUFG Intime India Private Limited
Phone: +91-22-4918 6270
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Lead Mangers

  1. Beeline Capital Advisors Pvt Ltd

Comments